Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Inadequate physical activity was associated with liver steatosis regardless of body mass index.
Resmetirom is the first drug to show both MASH resolution and fibrosis improvement in a late-stage clinical trial.
About 5% of veterans with dementia had evidence of liver cirrhosis, which can lead to cognitive impairment.
Even if exercise decreased over time, the benefits of vigorous physical activity were sustained in middle age.
People diagnosed with fatty liver disease before age 45 were about 50% more likely to develop cancer.
For both adolescents and adults, body mass index and waist circumference were linked to greater risk of MASLD.
People with acute pancreatitis, fatty liver disease and high triglyceride levels were more likely to experience persistent organ failure.
A personalized approach to diagnosis and treatment is needed when viral hepatitis and fatty liver disease coexist.
Cases of pediatric MASLD, formerly known as non-alcoholic fatty liver disease, are almost as common as asthma now.
Skipping breakfast and late-night eating can worsen MASLD, while intermittent fasting may help.
Aspirin helped reduce liver fat in people with metabolic dysfunction-associated steatotic liver disease, or MASLD.
More people who participated in a specialized program lost weight compared with those who received standard care.
Adolescents who utilized food assistance programs had better protection against MASLD.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.